170 related articles for article (PubMed ID: 11279081)
1. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.
Espinosa E; Belmant C; Pont F; Luciani B; Poupot R; Romagné F; Brailly H; Bonneville M; Fournié JJ
J Biol Chem; 2001 May; 276(21):18337-44. PubMed ID: 11279081
[TBL] [Abstract][Full Text] [Related]
2. Phosphoantigen presentation by macrophages to mycobacterium tuberculosis--reactive Vgamma9Vdelta2+ T cells: modulation by chloroquine.
Rojas RE; Torres M; Fournié JJ; Harding CV; Boom WH
Infect Immun; 2002 Aug; 70(8):4019-27. PubMed ID: 12117907
[TBL] [Abstract][Full Text] [Related]
3. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.
Gertner-Dardenne J; Bonnafous C; Bezombes C; Capietto AH; Scaglione V; Ingoure S; Cendron D; Gross E; Lepage JF; Quillet-Mary A; Ysebaert L; Laurent G; Sicard H; Fournié JJ
Blood; 2009 May; 113(20):4875-84. PubMed ID: 19278954
[TBL] [Abstract][Full Text] [Related]
4. Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay.
Rojas RE; Chervenak KA; Thomas J; Morrow J; Nshuti L; Zalwango S; Mugerwa RD; Thiel BA; Whalen CC; Boom WH
J Infect Dis; 2005 Nov; 192(10):1806-14. PubMed ID: 16235181
[TBL] [Abstract][Full Text] [Related]
5. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
Burjanadzé M; Condomines M; Reme T; Quittet P; Latry P; Lugagne C; Romagne F; Morel Y; Rossi JF; Klein B; Lu ZY
Br J Haematol; 2007 Oct; 139(2):206-16. PubMed ID: 17897296
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation.
Song Y; Zhang Y; Wang H; Raker AM; Sanders JM; Broderick E; Clark A; Morita CT; Oldfield E
Bioorg Med Chem Lett; 2004 Sep; 14(17):4471-7. PubMed ID: 15357974
[TBL] [Abstract][Full Text] [Related]
7. Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells.
Chargui J; Combaret V; Scaglione V; Iacono I; Péri V; Valteau-Couanet D; Dubrel M; Angevin E; Puisieux A; Romagne F; Bergeron C
J Immunother; 2010; 33(6):591-8. PubMed ID: 20551838
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli produces phosphoantigens activating human gamma delta T cells.
Feurle J; Espinosa E; Eckstein S; Pont F; Kunzmann V; Fournié JJ; Herderich M; Wilhelm M
J Biol Chem; 2002 Jan; 277(1):148-54. PubMed ID: 11675382
[TBL] [Abstract][Full Text] [Related]
9. TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell-Dependent Mechanism.
Duault C; Franchini DM; Familliades J; Cayrol C; Roga S; Girard JP; Fournié JJ; Poupot M
J Immunol; 2016 Jan; 196(1):493-502. PubMed ID: 26608919
[TBL] [Abstract][Full Text] [Related]
10. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of phosphoantigens: scalable accesses to enantiomers of BrHPP and studies on N-HDMAPP synthesis.
Brégeon D; Ferron L; Chrétien A; Guillen F; Zgonnik V; Rivaud M; Mazières MR; Coquerel G; Belmant C; Plaquevent JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5807-10. PubMed ID: 22902654
[TBL] [Abstract][Full Text] [Related]
12. Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate.
Soriano-Sarabia N; Sandvold H; Jomaa H; Kubin T; Bein G; Hackstein H
J Immunol; 2012 Dec; 189(11):5212-22. PubMed ID: 23105138
[TBL] [Abstract][Full Text] [Related]
13. In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.
Poccia F; Malkovsky M; Pollak A; Colizzi V; Sireci G; Salerno A; Dieli F
Mol Med; 1999 Jul; 5(7):471-6. PubMed ID: 10449808
[TBL] [Abstract][Full Text] [Related]
14. Vitamin C promotes the proliferation and effector functions of human γδ T cells.
Kouakanou L; Xu Y; Peters C; He J; Wu Y; Yin Z; Kabelitz D
Cell Mol Immunol; 2020 May; 17(5):462-473. PubMed ID: 31171862
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.
Bennouna J; Levy V; Sicard H; Senellart H; Audrain M; Hiret S; Rolland F; Bruzzoni-Giovanelli H; Rimbert M; Galéa C; Tiollier J; Calvo F
Cancer Immunol Immunother; 2010 Oct; 59(10):1521-30. PubMed ID: 20563721
[TBL] [Abstract][Full Text] [Related]
16. CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.
Peipp M; Wesch D; Oberg HH; Lutz S; Muskulus A; van de Winkel JGJ; Parren PWHI; Burger R; Humpe A; Kabelitz D; Gramatzki M; Kellner C
Scand J Immunol; 2017 Oct; 86(4):196-206. PubMed ID: 28708284
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate.
Boëdec A; Sicard H; Dessolin J; Herbette G; Ingoure S; Raymond C; Belmant C; Kraus JL
J Med Chem; 2008 Mar; 51(6):1747-54. PubMed ID: 18303828
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.
Martino A; Casetti R; Poccia F
Vaccine; 2007 Jan; 25(6):1023-9. PubMed ID: 17118497
[TBL] [Abstract][Full Text] [Related]
19. Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy.
Capietto AH; Martinet L; Cendron D; Fruchon S; Pont F; Fournié JJ
J Immunol; 2010 Jun; 184(12):6680-7. PubMed ID: 20483742
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of pyrophosphate-containing compounds that stimulate Vgamma2Vdelta2 T cells: application to cancer immunotherapy.
Tanaka Y; Kobayashi H; Terasaki T; Toma H; Aruga A; Uchiyama T; Mizutani K; Mikami B; Morita CT; Minato N
Med Chem; 2007 Jan; 3(1):85-99. PubMed ID: 17266628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
